Clinical trial
DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic…
NCT00077077 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00077077 |
|---|---|
| Title | DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Study Of The Combination Of Oral DJ-927 And Capecitabine In Patients With Advanced Solid Tumors |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | DJ-927, capecitabine |
| Start date | Feb 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Feb 11, 2004 |
| Last update posted | May 16, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: